{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:40Z","timestamp":1776329800190,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.6002\/ect.2024.0315","type":"journal-issue","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T10:24:26Z","timestamp":1755253466000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"23","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Yao FY, Gautam M, Palese C, et al. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant. 2006;20(5):617-623. doi:10.1111\/j.1399-0012.2006.00527.x","DOI":"10.1111\/j.1399-0012.2006.00527.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int. 2010;30(9):1247-1258. doi:10.1111\/j.1478-3231.2010.02303.x","DOI":"10.1111\/j.1478-3231.2010.02303.x"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Fu C, Li X, Chen Y, Long X, Liu K. Lung cancer incidences after liver transplantation: a systematic review and meta-analysis. Cancer Med. 2023;12(15):16119-16128. doi:10.1002\/cam4.6265","DOI":"10.1002\/cam4.6265"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Pesthy S, Wegener E, Ossami Saidy RR, et al. Reducing immunosuppression in patients with de novo lung carcinoma after liver transplantation could significantly prolong survival. Cancers (Basel). 2022;14(11):2748. doi:10.3390\/cancers14112748","DOI":"10.3390\/cancers14112748"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wang BY, Huang JY, Chen HC, et al. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol. 2020;146(1):43-52. doi:10.1007\/s00432-019-03079-8","DOI":"10.1007\/s00432-019-03079-8"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Krynitz B, Edgren G, Lindel\u00f6f B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008: a Swedish population-based study. Int J Cancer. 2013;132(6):1429-1438. doi:10.1002\/ijc.27765","DOI":"10.1002\/ijc.27765"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Harwood CA, Toland AE, Proby CM, et al; KeraCon Consortium. The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017;177(5):1217-1224. doi:10.1111\/bjd.15956","DOI":"10.1111\/bjd.15956"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Denisov EV, Schegoleva AA, Gervas PA, et al. Premalignant lesions of squamous cell carcinoma of the lung: the molecular make-up and factors affecting their progression. Lung Cancer. 2019;135:21-28. doi:10.1016\/j.lungcan.2019.07.001","DOI":"10.1016\/j.lungcan.2019.07.001"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Leong LY, Lin PC, Chi CY, et al. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect. 2021;54(2):312-318. doi:10.1016\/j.jmii.2019.08.006","DOI":"10.1016\/j.jmii.2019.08.006"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S. Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania. Int J Tuberc Lung Dis. 2016;20(6):757-763. doi:10.5588\/ijtld.15.0783","DOI":"10.5588\/ijtld.15.0783"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Su VY, Yen YF, Pan SW, et al. Latent tuberculosis infection and the risk of subsequent cancer. Medicine (Baltimore). 2016;95(4):e2352. doi:10.1097\/MD.0000000000002352","DOI":"10.1097\/MD.0000000000002352"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Qin Y, Chen Y, Chen J, Xu K, Xu F, Shi J. The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future. Infect Agent Cancer. 2022;17(1):20. doi:10.1186\/s13027-022-00434-2","DOI":"10.1186\/s13027-022-00434-2"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Kuo CH, Lo CY, Chung FT, et al. Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country. PLoS One. 2012;7(3):e33226. doi:10.1371\/journal.pone.0033226","DOI":"10.1371\/journal.pone.0033226"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Nalbandian A, Yan BS, Pichugin A, Bronson RT, Kramnik I. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene. 2009;28(17):1928-1938. doi:10.1038\/onc.2009.32","DOI":"10.1038\/onc.2009.32"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Hwang SY, Kim JY, Lee HS, et al. Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis. J Clin Med. 2022;11(3):765. doi:10.3390\/jcm11030765","DOI":"10.3390\/jcm11030765"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T10:38:14Z","timestamp":1755254294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2025\/23\/7\/0\/501\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2024.0315","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}